Skip to main content
Signal8

Mirion Technologies, Inc. (MIR)

Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).

Sector: Measuring & Controlling Devices, NEC

Industry: Industrial - Machinery

Mirion Technologies, Inc. logo

Mirion Technologies, Inc.

NYSE:MIRIndustrials
Pre+0.61%$14.90
Close$14.81-0.74%AH Close$14.81+0.61%since
Mkt Cap$3.69B
Float222.65M
O/S249.04M
Inst Own-
SI17.2%
Dilution
Mirion Technologies, Inc. logoNYSE:MIRPre$14.90+0.61%
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$3.69B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 249.04M shares outstanding

SectorIndustrials
IndustryIndustrial - Machinery
ExchangeNYSE
CountryUSUS
IPO DateAug 20, 2020
Shares Outstanding249.04M
Float222.65M
Company Overview

Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia.

The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring.

Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries.

It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).

Leadership

Alison Ulrich

Chief Human Resources Officer

Brian Schopfer

CFO & Medical Group President

Emmanuelle Lee

Executive VP, Chief Legal Officer, Chief Compliance Officer & Secretary

Loic Eloy

Group President of Nuclear & Safety Technologies

Employees

3K+

Country

US

Sector

Industrials

Website

mirion.com

Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target (median, last 90d)
$21.50+45.2%
Low $20High $24
Ratings Distribution
BUY
8
HOLD
1
SELL
0
TOTAL9
Insider Trading
InsiderTypeShares
Schopfer Brian profile photoSchopfer BrianPurchase20.0K
Bockhorst Kenneth profile photoBockhorst KennethGrant/Award7.4K
Kingsley Lawrence D profile photoKingsley Lawrence DGrant/Award7.4K
Rege Sheila profile photoRege SheilaGrant/Award7.4K
Markopoulos Jody profile photoMarkopoulos JodyGrant/Award7.4K
KUO JOHN W profile photoKUO JOHN WGrant/Award7.4K
Shareholders
-
Institutionalⓘ
(354)
0.7%
Insiderⓘ
(13)
3.8%
5%+ Owners
(1)
of which 3.8% rests on schedules older than 24 months (1 holder)
-
Unattributed (incl. retail)ⓘ
Insider0.7%
5%+ Beneficial3.8%
Sources: 13F, Form 4, 13D/13GO/S: 249.0M · checked 25 Oct 2026 · market-data provider
Insiders & Institutional Holders
52-Week Range
$14.04$30.28
$14.81(5th percentile)
Volume
Average Daily Volume4.13M
2.29M today vs 4.13M avg(-44%)

30d Avg

4.13M

60d Avg

3.96M

90d Avg

4.01M

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...